Jeb Ledell

Jeb Ledell is an accomplished executive with extensive experience in the biopharmaceutical industry, currently serving as Chief Operating Officer at KalVista Pharmaceuticals, Inc. since December 2024. Prior to this role, Jeb held the Chief Operating Officer position at AVEO Oncology and Enzyvant, demonstrating a consistent track record of leadership. Jeb's career includes significant roles at Compass Therapeutics LLC, Horizon Discovery Group, and Zalicus Incorporated, where responsibilities encompassed both operational and technological oversight. Earlier career achievements at CombinatoRx, Inc. and Cibeo Software LLC highlight expertise in informatics and engineering applications. Jeb Ledell holds a Bachelor of Science in Chemical Engineering from Worcester Polytechnic Institute, earned in 1997.